60 Degrees Pharmaceuticals, Inc.
SXTP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $614.8K in total; no superinvestor holds it.
Other share classesSXTPW
Q1 2026 vs. Q4 2025
How the institutions holding 60 Degrees Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 7 | 8 | +1 |
| Shares | 44.4K | 194.3K | +150.0K (+338.1%) |
| Value | $22.5K | $340.1K | +$317.5K (+1,408.3%) |
New holders (4)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kathmere Capital Management, LLC | 144,683 | $253.2K | 0.02% |
| GWM Advisors LLC | 50 | $88 | 0.00% |
| Twin Peaks Wealth Advisors, LLC | 8 | $14 | 0.00% |
| Citigroup Inc | 1 | $2 | 0.00% |
Sold out (3)
Institutions that held 60 Degrees Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 22,051 | $11.2K |
| Tower Research Capital LLC (TRC) | 6,738 | $3.42K |
| Bank of America Corp | 31 | $16 |